Informação sobre produto
- rel-6,7-Dimethyl (1R,5R,6R,7S)-4-oxo-8-(phenylmethyl)-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylate
- 8-Azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid, 4-oxo-8-(phenylmethyl)-, 6,7-dimethyl ester, (1R,5R,6R,7S)-rel-
SD 1008 is a histone lysine modulator that has been shown to improve memory in animal models of Alzheimer's disease. It works by binding to the active site of the enzyme acetylcholinesterase, which breaks down the brain chemical acetylcholine. SD 1008 also reduces virus-induced cell degranulation and synapses in mouse brains. It is a conjugate of pyridine compounds with polymer chains that signal transducers and are targeted for cancer therapy. The structure of SD 1008 is similar to other drug molecules that have been developed for cancer treatment, including drugs targeting integrin receptors. This similarity may be useful when treating cancers that express this receptor as it may help reduce side effects caused by these drugs.
Propriedades químicas
Consulta técnica sobre: 3D-KNB20181 SD 1008
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.